Studies in Scleroderma and Cystic Fibrosis Osteoporosis
Studies in Scleroderma and Cystic Fibrosis Osteoporosis
批准号:
6612726
负责人:
PETER A MERKEL
金额:
$12.18万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-18 至 2006-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): To provide support for research projects
in the field of rheumatology that will form the basis of a structured mentoring
program for young investigators pursuing careers in patient-oriented clinical
research. This application has two major specific research aims: 1) Develop new
outcome measures for skin assessment in scleroderma for use in clinical trials
and 2) Determine the prevalence and progression of osteoporosis in patients
with cystic fibrosis (CF). Both projects will have direct relevance to
furthering the health of the populations under study. Clinical research in
scleroderma, including therapeutic trials, is greatly hampered by a lack of
reliable and precise outcome measurements of disease activity. Skin thickening
and fibrosis are major causes of morbidity and dysfunction for patients with
scleroderma. The great success in extending the life expectancy of patients
with CF gained in the last 20 years has resulted in patients now experiencing
diseases as adults not formerly encountered in this population. Among these
diseases is osteoporosis. Patients with CF appear to be at high risk for
osteoporosis due to nutritional, pharmacologic, and genetic factors but the
pathophysiology and extent of the problem is not known. Patients with
scleroderma will be followed prospectively and evaluated for skin disease
activity by skin scoring, durometer readings (thickness), light-based
technologies, skin biopsies, self-assessments, and functional status
instruments. These data will be analyzed to determine a core set of outcome
measures for scleroderma. and validated by an expert panel of national
researchers in this disease. An observational cohort of patients with CF will
be studied. Baseline and 2-year measurements of bone density, nutritional
status, and biochemical markers of bone turnover will performed. A
comprehensive program for training new clinical investigators by the principal
investigator is proposed. This program includes trainees taking an active and
integral role in the research studies described. Additionally, trainees will be
enrolled in formal coursework in biostatistics, epidemiology, and clinical
research techniques leading to a master degree. A unique seminar and a series
of support services at the host institution will further complement the
training program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASE
-
批准号:7167055
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2005
-
负责人:PETER A MERKEL
-
依托单位:
GENETIC POLYMORPHISMS IN WEGENER'S GRANULOMATOSIS
-
批准号:7206265
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2004
-
负责人:PETER A MERKEL
-
依托单位:
DEVELOPMENT AND VALIDATION OF OUTCOME MEASURES FOR SYSTEMIC SCLEROSIS
-
批准号:7206245
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2004
-
负责人:PETER A MERKEL
-
依托单位:
STUDY OF ENBREL IN THE TREATMENT OF WEGENER'S GRANULOMATOSIS
-
批准号:7206313
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2004
-
负责人:PETER A MERKEL
-
依托单位:
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASE
-
批准号:6982997
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2004
-
负责人:PETER A MERKEL
-
依托单位:
Vasculitis Clinical Research Network (VCRN)
-
批准号:6745899
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
Vasculitis Clinical Research Network (VCRN)
-
批准号:6806068
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
Study of Enbrel in Treatment of Wegener's Granulomatosis
-
批准号:7042230
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
Vasculitis Clinical Research Network (VCRN)
-
批准号:6941107
-
项目类别:
-
资助金额:$125.0万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
Genetic Polymorphisms in Wegener's Granulomatosis
-
批准号:7042185
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
CLINICAL AND BIOCHEMICAL MARKERS OF OSTEOPOROSIS IN PTS WITH CYSTIC FIBROSIS
-
批准号:6982540
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
Outcome Measures for Systemic Sclerosis
-
批准号:7042164
-
项目类别:
-
资助金额:$0.69万
-
财政年份:2003
-
负责人:PETER A MERKEL
-
依托单位:
CLINICAL AND BIOCHEMICAL MARKERS OF OSTEOPOROSIS IN CYSTIC FIBROSIS
-
批准号:6586455
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2002
-
负责人:PETER A MERKEL
-
依托单位:
PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
-
批准号:6586446
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2002
-
负责人:PETER A MERKEL
-
依托单位:
Studies in Scleroderma and Cystic Fibrosis Osteoporosis
-
批准号:6511751
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
-
批准号:6574413
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
CLINICAL AND BIOCHEMICAL MARKERS OF OSTEOPOROSIS IN CYSTIC FIBROSIS
-
批准号:6574422
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
Studies in Scleroderma and Cystic Fibrosis Osteoporosis
-
批准号:6930427
-
项目类别:
-
资助金额:$12.76万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
Studies in Scleroderma and Cystic Fibrosis Osteoporosis
-
批准号:6369945
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
Studies in Scleroderma and Cystic Fibrosis Osteoporosis
-
批准号:6780976
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2001
-
负责人:PETER A MERKEL
-
依托单位:
海外基金